The Investment objective of the Scheme is to provide returns that, before expenses, corresponds to the total return of the securities as represented by the underlying index, subject to tracking error.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -5.28% | -7.42% | -4.2% | -8.02% | -8.82% | N/A | N/A | N/A | N/A | N/A | -5.63% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.18% | N/A |
| Absolute returns | -5.28% | -7.42% | -4.2% | -8.02% | -8.82% | N/A | N/A | N/A | N/A | N/A | -10.38% |
| Rank within category | 164/216 | 188/207 | 135/199 | 154/193 | 140/184 | N/A | N/A | N/A | N/A | N/A | N/A |
| Index Funds | 2024 | 2025 | 2026 |
|---|---|---|---|
| Yearly returns | N/A | -0.76% | -8.62% |
| Q1 returns | N/A | -7.84% | -11.65% |
| Q2 returns | N/A | 8.16% | 9.66% |
| Q3 returns | N/A | -4.36% | -3.87% |
| Q4 returns | N/A | 4.09% | -1.9% |
Nil
| Alpha | -0.0876635 |
| Beta | 0.9973 |
| Sharpe Ratio | -0.214797 |
| Sortino Ratio | -0.317351 |
| R-Squared | 0.9949 |
| Tracking Error | 0.097 |
| Downside Risk | 20.4365 |
| Std. Deviation (Annualised) | 13.7062 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.21 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| UTI Nifty Alpha Low-Volatility 30 Index Fund - Regular Plan - Growth Current | -5.28% | -7.42% | -4.2% | -8.02% | -8.82% | N/A | N/A | N/A | -5.63% | 63.43 | 1.24 | -0.21 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.72% |
| NTPC Ltd. | Power | Domestic Equities | 4.10% |
| Bajaj Auto Ltd. | Automobiles | Domestic Equities | 4.00% |
| Marico Ltd. | Agricultural Food & other Products | Domestic Equities | 3.97% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 3.91% |
| Hindalco Industries Ltd. | Non - Ferrous Metals | Domestic Equities | 3.79% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 3.76% |
| Nestle India Ltd. | Food Products | Domestic Equities | 3.71% |
| JSW Steel Ltd. | Ferrous Metals | Domestic Equities | 3.61% |
| Grasim Industries Ltd. | Cement & Cement Products | Domestic Equities | 3.60% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.59% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 3.53% |
| SBI Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.52% |
| Cummins India Ltd. | Industrial Products | Domestic Equities | 3.48% |
| Bharti Airtel Ltd. | Telecom - Services | Domestic Equities | 3.32% |
| Titan Company Ltd. | Consumer Durables | Domestic Equities | 3.25% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.23% |
| TVS Motor Company Ltd. | Automobiles | Domestic Equities | 3.22% |
| State Bank Of India | Banks | Domestic Equities | 3.13% |
| Pidilite Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 3.05% |
| Coal India Ltd. | Consumable Fuels | Domestic Equities | 3.04% |
| Eicher Motors Ltd. | Automobiles | Domestic Equities | 3.02% |
| Britannia Industries Ltd. | Food Products | Domestic Equities | 2.90% |
| Reliance Industries Ltd. | Petroleum Products | Domestic Equities | 2.81% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.78% |
| Ultratech Cement Ltd. | Cement & Cement Products | Domestic Equities | 2.74% |
| Asian Paints Ltd. | Consumer Durables | Domestic Equities | 2.71% |
| Maruti Suzuki India Ltd. | Automobiles | Domestic Equities | 2.50% |
| Tata Consumer Products Ltd. | Agricultural Food & other Products | Domestic Equities | 2.48% |
| Max Financial Services Ltd. | Insurance | Domestic Equities | 2.18% |
| NET CURRENT ASSETS | Cash & Cash Equivalents and Net Assets | 0.36% | |
| Total | 100.00% | ||
Mr. Goyal began his career with UTI AMC in June 2006 and has 19 years of overall experience in Risk / Fund management. Presently he is working as Fund Manager for Schemes of UTI Mutual Fund.
Mr. Jain is a manager and designated as Assistant Fund Manager at UTI AMC Ltd. He is a Chartered Accountant holding charter from Institute of Chartered Accountants of India and B.COM from DAVI Ahilya University. He began his career with UTI AMC Ltd in April, 2018 and has over 7 years of experience in Equity Fund Management, Equity research, Equity Portfolio Analysis & Portfolio Management Services.
Get personalized portfolio management services designed to grow and protect your wealth.